Us Bancorp \De\ Repligen Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Repligen Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 10,032 shares of RGEN stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,032

Previous 10,293 2.54%

Holding current value

$1.45 Million

Previous $1.3 Million 15.03%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$119.79 - $167.35 $31,265 - $43,678	-261 Reduced 2.54%	10,032 $1.49 Million
Q2 2024 Aug 06, 2024	BUY	$120.0 - $182.95 $115,560 - $176,180	963 Added 10.32%	10,293 $1.3 Million
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $422,851 - $516,047	-2,476 Reduced 20.97%	9,330 $1.72 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $241,355 - $391,829	2,114 Added 21.81%	11,806 $2.12 Million
Q3 2023 Nov 03, 2023	BUY	$138.78 - $176.51 $322,247 - $409,856	2,322 Added 31.51%	9,692 $1.54 Million
Q2 2023 Aug 09, 2023	SELL	$138.42 - $180.31 $273,102 - $355,751	-1,973 Reduced 21.12%	7,370 $1.04 Million
Q1 2023 May 09, 2023	SELL	$154.26 - $198.1 $1.11 Million - $1.43 Million	-7,196 Reduced 43.51%	9,343 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $325,976 - $442,663	-2,007 Reduced 10.82%	16,539 $2.8 Million
Q3 2022 Oct 27, 2022	SELL	$160.42 - $256.21 $696,864 - $1.11 Million	-4,344 Reduced 18.98%	18,546 $3.47 Million
Q2 2022 Aug 01, 2022	BUY	$140.68 - $188.02 $715,357 - $956,081	5,085 Added 28.56%	22,890 $3.72 Million
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $216,316 - $346,182	1,342 Added 8.15%	17,805 $3.35 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $150,534 - $185,117	608 Added 3.83%	16,463 $4.36 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $1.67 Million - $2.78 Million	8,588 Added 118.18%	15,855 $4.58 Million
Q2 2021 Aug 05, 2021	BUY	$165.87 - $220.95 $150,609 - $200,622	908 Added 14.28%	7,267 $1.45 Million
Q1 2021 Apr 28, 2021	BUY	$180.37 - $226.26 $95,054 - $119,239	527 Added 9.04%	6,359 $1.24 Million
Q4 2020 Feb 04, 2021	BUY	$148.08 - $206.57 $346,507 - $483,373	2,340 Added 67.01%	5,832 $1.12 Million
Q3 2020 Nov 10, 2020	SELL	$122.51 - $158.27 $74,731 - $96,544	-610 Reduced 14.87%	3,492 $515,000
Q2 2020 Aug 07, 2020	SELL	$94.33 - $140.48 $85,651 - $127,555	-908 Reduced 18.12%	4,102 $508,000
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $26,847 - $34,488	316 Added 6.73%	5,010 $483,000
Q4 2019 Feb 04, 2020	BUY	$73.84 - $93.08 $59,293 - $74,743	803 Added 20.64%	4,694 $434,000
Q3 2019 Nov 08, 2019	BUY	$76.65 - $95.51 $28,283 - $35,243	369 Added 10.48%	3,891 $298,000
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $23,577 - $37,388	435 Added 14.09%	3,522 $302,000
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $23,888 - $34,095	-495 Reduced 13.82%	3,087 $162,000
Q1 2018 May 08, 2018	SELL	$30.92 - $37.27 $1,329 - $1,602	-43 Reduced 1.19%	3,582 $129,000
Q4 2017 Feb 02, 2018	BUY	$32.53 - $38.92 $32 - $38	1 Added 0.03%	3,625 $132,000
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $134,015 - $166,921	3,624	3,624 $139,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account